Marcus Katoh Selected Research

Gadolinium DTPA (Magnevist)

9/2004

In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus Katoh Research Topics

Disease

6	Stroke (Strokes) 09/2023 - 09/2008
5	Thrombosis (Thrombus) 11/2007 - 04/2004
4	Ischemic Stroke 09/2023 - 11/2022
3	Venous Thrombosis (Deep-Vein Thrombosis) 03/2009 - 04/2004
2	Pain (Aches) 01/2022 - 11/2020
2	Neoplasms (Cancer) 01/2022 - 07/2004
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 03/2010
2	Shock 11/2007 - 04/2004
2	Pulmonary Embolism 08/2007 - 08/2005
2	Coronary Thrombosis 03/2005 - 09/2004
1	Aortic Aneurysm (Aneurysm, Aortic) 11/2021
1	Aneurysm (Aneurysms) 11/2021
1	Tendinopathy (Tendonitis) 11/2020
1	Arthralgia (Joint Pain) 11/2020
1	Mesenteric Ischemia 01/2018
1	Ischemia 01/2017
1	Renal Insufficiency (Renal Failure) 06/2014
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Peripheral Arterial Disease 10/2012
1	Hemorrhage 08/2012
1	Obesity 08/2012
1	Pathologic Constriction (Stenosis) 09/2010
1	Abdominal Pain (Pain, Abdominal) 03/2010
1	Fever (Fevers) 03/2010
1	Abscess 03/2010
1	Gallstones (Gallstone) 03/2010
1	Renal Artery Obstruction (Renal Artery Stenosis) 10/2007
1	Pneumothorax 11/2006
1	Infections 11/2006
1	Acute Coronary Syndrome 09/2004

Drug/Important Bio-Agent (IBA)

7	Contrast MediaIBA 12/2021 - 09/2004
5	FibrinIBA 03/2009 - 09/2004
5	EP-2104RIBA 09/2008 - 09/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2007 - 04/2004
1	Cytidine Triphosphate (CTP)IBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Fibroblast Growth Factor-23IBA 01/2017
1	CreatinineIBA 01/2017
1	Cystatin CIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2014
1	Heparin (Liquaemin)FDA LinkGeneric 10/2012
1	Phenobarbital (Luminal)FDA Link 09/2010
1	Thrombin FDA Link 11/2007
1	GadoliniumIBA 09/2004
1	Gadolinium DTPA (Magnevist)FDA Link 09/2004
1	Fibrinogen (Factor I)FDA Link 09/2004
1	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2004
1	PPAR gammaIBA 07/2004
1	Carcinoembryonic AntigenIBA 07/2004
1	SiliconIBA 04/2004

Therapy/Procedure

7	Thrombectomy 09/2023 - 04/2004
4	Catheters 01/2018 - 11/2006
3	Punctures 08/2023 - 08/2012
3	Therapeutics 01/2022 - 11/2020
2	Stents 10/2012 - 09/2004
1	Length of Stay 09/2023
1	Conscious Sedation 08/2023
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Endovascular Aneurysm Repair 11/2021
1	Vascular Closure Devices 08/2012
1	Laparoscopic Cholecystectomy 03/2010